Search results
Novel URAT1 Inhibitors Advance for Gout
MedPage Today· 3 days agoImproved drugs to force uric acid excretion as a means of treating gout are inching closer to clinical availability in the U.S., with new data reported...
...In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry...
KOLR - KSFX Ozarks· 3 days agoYork on Wednesday, June 26, 2024 at 8:30 a.m. Eastern Daylight Time (EDT). Aleš Linhart, DSc, FESC (Charles University, Prague), who will discuss the treatment landscape for ...
Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for...
KPVI· 2 days agogout. "We are excited to share new data from our Phase 2 trial of AR882 highlighting its long-term durability of effect and strong safety profile, further building on the ...
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
Morningstar· 4 days agoData Highlight Positive Outcomes in Uncontrolled Gout With KRYSTEXXA® and Progress in Addressing Sjögren's Disease THOUSAND OAKS, Calif., June 12, 2024 /PRNewswire/ -- Amgen ...
Scilex's SP-102 shows promise for sciatica pain relief By Investing.com
Investing.com· 2 days agoScilex Holding Company (NASDAQ:SCLX), a company specializing in non-opioid pain management, has...
Teachers Retirement System of The State of Kentucky Sells 2,047 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 7 hours agoTeachers Retirement System of The State of Kentucky trimmed its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.5% during the 4th quarter, according to the company in its most recent ...
'I was in the shape of my life but now I can barely button up a shirt'
Daily Express· 5 days agoAlison McIndoe, a personal trainer, initially attributed her knee pain to excessive gym workouts. At...
Auxier Asset Management Lowers Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 11 hours agoAuxier Asset Management lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ...
Scilex (NASDAQ:SCLX) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 5 days agoHC Wainwright reaffirmed their buy rating on shares of Scilex (NASDAQ:SCLX – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently ...
DASH vs. the Mediterranean Diet: Heart-Healthy, But Very Different
The Sacramento Bee· 3 days agoThe DASH diet and the Mediterranean diet have similar cardiovascular, immunity and weight loss benefits. Jordan Hill, RD, of Top Nutrition Coaching tells Woman’s World that although DASH is ...
